Send feedback

TELO2 p.Arg403Ter

c.1207C>T · rs572431474 · VCV1927535

Pathogenic/Likely pathogenic Multiple submitters
Classification
Pathogenic/Likely pathogenic
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 4 submitters
Consequence
nonsense (stop-gain)
predicted LoF
gnomAD v4.1
Rare
very rare (popmax 0.00333%, amr)
Conditions
1
TELO2-related intellectual disability-neurodevelopmental disorder

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Consequencenonsense (stop-gain)predicted loss-of-function
NMDpredictedpremature termination codon in exon 9 of 21
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 7.5GERP 1.9, phastCons 1
Overall
CADD39.0PHRED · no single calibrated threshold — expert panels disagree

Predicted loss-of-function is descriptive, not an applied PVS1 code.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00333% Admixed American · 2/59,994 alleles
Filtering AF 0.000553% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.000313%
Overall 0.00093% 15/1,612,392 alleles · very rare
Ancestry group Frequency 1 in
Admixed Americangrpmax 0.00333% 29,997
South Asian 0.0022% 45,518
Remaining individualsnot grpmax-eligible 0.0016% 62,454
European (non-Finnish) 0.000848% 117,977

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
TELO2
Protein
p.Arg403Ter
Coding
c.1207C>T
MANE Select
NM_016111
dbSNP
rs572431474
Type
single nucleotide variant
Location
chr16:1500625 (GRCh38)
Gene constraint
LOEUF 1.03 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 84.74 · 4 PDB
Residue 403
an α-helix
Full TELO2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/telo2-p-arg403ter (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown